- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.08. | AI, genomics expert leaves Pathos AI, will advise Pfizer | ||
| 21.08. | Positive Ph1 results for AC Immune's NLRP3 inflammasome inhibitor | ||
| 21.08. | Akeso and CStone secure China clearances for next-generation ADCs | ||
| 21.08. | Bioptimus, Cancer Research Horizons partner on AI-powered precision medicine | ||
| 20.08. | Claude Science outperforms experts in protein binder task | ||
| 20.08. | Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa | ||
| 20.08. | Trump taps White House aide Heidi Overton to lead FDA | ||
| 20.08. | $31.1m ARPA-H funding for Siemens endovascular robotics | ||
| 20.08. | Akiram, ITM sign Lutetium-177 supply agreement | ||
| 19.08. | FDA greenlights Regeneron drug for rare bone disease | ||
| 19.08. | MSD, Moderna skin cancer vaccine scores historic phase 3 win | ||
| 19.08. | $50m Network Bio launch & NVIDIA collaboration | ||
| 19.08. | Medable, Tufts CSDD value AI gain at $21m net per programme | ||
| 19.08. | LEO Pharma pens $435m deal for Tanabe Pharma's dersimelagon | ||
| 18.08. | BioMarin snaps up Alesta's lead asset for $275M | ||
| 18.08. | AstraZeneca's volrustomig hits Phase 3 setback in lung cancer | ||
| 18.08. | Sandoz adds 10 biosimilars through $322m Henlius deal | ||
| 18.08. | MHRA clarifies UK position on microbiome-based medicines | ||
| 18.08. | Australia first for Hansa's Idefirix in commercial kidney transplant | ||
| 17.08. | After failure in sickle cell, Fulcrum Therapeutics merges with Slate Medicines | ||
| 17.08. | Sanofi to lay off 229 Blueprint employees, close offices | ||
| 17.08. | OpenAI Foundation pledges $100m to boost hepatitis C cure rates | ||
| 17.08. | Capricor's DMD hope still strong, as it shares financials | ||
| 17.08. | Tauklarify PET approval for Lantheus in AD NFT pathology | ||
| 14.08. | Vogenx surpasses expectations with $81M IPO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.